This inventor holds 2 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Suzhou Alphamab Co., Ltd., Suzhou Alphamab Co., Ltd.. Active years: 2022-2026.
Company Filing History:
Years Active: 2022-2026
Title: Yanrong Dong: Innovator in Medical Biology
Introduction
Yanrong Dong is a prominent inventor based in Jiangsu, China. He has made significant contributions to the field of medical biology, particularly in the development of therapeutic antibodies. His innovative work focuses on addressing critical health challenges, including cancer.
Latest Patents
Yanrong Dong holds a patent for a single domain antibody and derivative proteins against programmed death-ligand 1 (PDL1). This invention is crucial for the treatment, prevention, and diagnosis of PDL1 relevant diseases, such as tumors. The patent highlights the potential of his binding molecule to revolutionize therapeutic approaches in oncology.
Career Highlights
Dong is associated with Suzhou Alphamab Co., Ltd., where he continues to advance his research and development efforts. His work has garnered attention for its potential impact on cancer treatment and patient outcomes. With 1 patent to his name, he is recognized as a key figure in his field.
Collaborations
He collaborates with notable colleagues, including Ting Xu and Pilin Wang, who contribute to the innovative environment at Suzhou Alphamab Co., Ltd. Their combined expertise fosters a dynamic research atmosphere that drives forward-thinking solutions in medical biology.
Conclusion
Yanrong Dong's contributions to medical biology through his innovative patent demonstrate his commitment to improving healthcare. His work in developing targeted therapies showcases the potential for advancements in cancer treatment.